Maternal Hypertension: Diagnosis and Antihypertensive Choices

High blood pressure during pregnancy is common, clinically important and treatable. It may reflect chronic hypertension that existed before conception, develop after 20 weeks as gestational hypertension, or occur with pre-eclampsia, a multisystem disorder that can affect the kidneys, liver, brain, placenta and fetus. Early recognition helps clinicians protect both parent and baby while avoiding medicines that may cause fetal harm.

For Australian families, care may involve a general practitioner, midwife, obstetrician, maternal-fetal medicine specialist and hospital maternity team. The right plan depends on gestational age, blood pressure readings, symptoms, blood and urine results, fetal growth and access to urgent services. Medication decisions should be individualised rather than based on a single home reading or a friend’s experience.

Recognising the different forms of hypertension

Hypertension in pregnancy is generally defined as a blood pressure of at least 140/90 mmHg, confirmed with appropriate repeat measurements. Chronic hypertension is present before pregnancy or diagnosed before 20 weeks. Gestational hypertension begins after 20 weeks without clear evidence of organ injury, while pre-eclampsia involves new hypertension plus proteinuria or maternal organ dysfunction, with or without protein in the urine.

Warning symptoms require prompt assessment. These include a persistent headache, visual disturbances, pain under the ribs or in the upper abdomen, sudden swelling of the face or hands, shortness of breath, confusion, vomiting or a noticeable reduction in fetal movements. A reading of 160/110 mmHg or higher is severe-range hypertension and should be treated as an urgent obstetric problem, particularly when it persists.

The relationship between emotional wellbeing and pregnancy physiology is complex. Stress does not cause every case of hypertension, but sleep disruption, anxiety and sustained psychological strain can affect behaviour, blood pressure and engagement with care. Research discussions such as maternal stress and fetal development can help clinicians explain why emotional support belongs alongside physical monitoring.

Confirming the diagnosis safely

Blood pressure should be measured with a validated device, a correctly sized cuff and the arm supported at heart level. The patient should rest quietly for several minutes, avoid talking during the reading and repeat an unexpected result. Home monitoring can be useful, especially for detecting a white-coat effect, but devices should be checked against clinic equipment and should never delay assessment of severe readings or concerning symptoms.

The diagnostic assessment usually includes a urine protein test and blood tests for a full blood count, platelet count, creatinine, electrolytes, liver enzymes and, when clinically indicated, haemolysis markers. A protein-to-creatinine ratio of 30 mg/mmol or more is commonly used in Australian practice as significant proteinuria. However, pre-eclampsia can occur without proteinuria when there is thrombocytopenia, kidney impairment, liver dysfunction, pulmonary oedema, neurological symptoms or placental complications.

Fetal assessment may include ultrasound growth measurement, amniotic fluid assessment, umbilical artery Doppler studies and cardiotocography, depending on gestation and risk. A person receiving shared antenatal care through a GP in Melbourne or Sydney may be referred to a hospital hypertension clinic, while someone in regional Queensland or Western Australia may need coordinated telehealth and transport planning. The diagnosis should account for the whole clinical picture rather than a number in isolation.

Selecting an antihypertensive during pregnancy

The preferred medicine depends on severity, previous treatment, side effects, comorbidities and local formulary arrangements. Labetalol is often selected when there is no asthma, bradycardia or relevant cardiac conduction problem. Nifedipine, usually in an extended-release form for ongoing control, is useful when a beta blocker is unsuitable. Methyldopa has a long history of pregnancy use but can cause sedation, low mood and dizziness, so it is less attractive for some patients.

For chronic hypertension, clinicians generally aim to reduce maternal stroke and placental risks without causing symptomatic hypotension or compromising uteroplacental perfusion. The treatment threshold and target should be documented clearly. A medication that worked before pregnancy may need changing, and dose adjustments are common as blood pressure and plasma volume change.

ACE inhibitors such as perindopril and ramipril, angiotensin receptor blockers such as irbesartan and candesartan, and direct renin inhibitors should generally be stopped and replaced when pregnancy is recognised. They can cause fetal kidney injury, low amniotic fluid and neonatal complications. Diuretics are not routine first-line choices for pregnancy hypertension, although a specialist may use them for particular cardiac or fluid-related indications.

Access matters in Australia. Labetalol and nifedipine are familiar options in public maternity services, while PBS arrangements, pharmacy stock and local hospital protocols can influence continuity after discharge. A written prescription and clear handover are particularly important before weekends, public holidays or travel between towns.

Responding to severe or complicated disease

Persistent severe blood pressure is an emergency because it increases the risk of intracranial haemorrhage, placental abruption, heart failure and other maternal complications. Treatment should occur in an obstetric or hospital setting with repeated blood pressure checks, intravenous access, blood tests and assessment of fetal wellbeing. Immediate-release nifedipine, intravenous labetalol or intravenous hydralazine may be used according to the hospital protocol and the patient’s clinical circumstances.

Antihypertensive treatment lowers the pressure; it does not remove the underlying risk of pre-eclampsia. Magnesium sulfate may be recommended for seizure prevention or treatment when neurological symptoms, severe pre-eclampsia or an imminent birth makes it appropriate. It is not a substitute for blood pressure control. Corticosteroids may be considered when preterm birth is likely, to support fetal lung maturation, while the timing of delivery balances maternal deterioration against gestational age.

A severe headache, visual change, chest pain, breathlessness, seizure, heavy bleeding or reduced fetal movement warrants urgent help. In Australia, calling 000 is appropriate for a medical emergency; otherwise, the maternity assessment unit or hospital used for antenatal care should provide the local pathway. Self-adjusting doses at home is unsafe, particularly with short-acting medicines.

Monitoring treatment and planning birth

Follow-up frequency is based on severity and gestation. A person with stable chronic hypertension may have regular home readings and scheduled reviews, while gestational hypertension often requires frequent blood tests, symptom checks and fetal surveillance. Clinicians should review adherence without judgement, ask about dizziness and headaches, and check whether the patient can obtain the medicine reliably from a community pharmacy.

Fetal growth restriction is a recognised complication of placental disease and hypertension. Serial ultrasound scans and Doppler studies can identify concerning trends, although a normal scan does not guarantee that maternal disease will remain stable. Birth planning should cover the preferred hospital, transport, neonatal support, induction or caesarean considerations, and what to do if symptoms arise before the next appointment.

Blood pressure can worsen after birth, often peaking several days postpartum. Discharge instructions should include a monitoring schedule, medication plan, warning symptoms and a review date. Breastfeeding-compatible choices are usually available, but treatment still requires attention to renal function, fluid balance and the possibility of delayed pre-eclampsia. Persistent hypertension beyond the postpartum period needs cardiovascular risk assessment and long-term follow-up.

Reducing risk through coordinated care

Risk assessment begins before conception when possible. People with previous pre-eclampsia, chronic hypertension, kidney disease, diabetes, autoimmune disease, multiple pregnancy or a strong family history may benefit from specialist planning. Low-dose aspirin is recommended for selected high-risk pregnancies in Australian guidance, commonly from around 12 weeks until late pregnancy, but the dose and start date must be confirmed by the treating clinician. Aspirin is preventive; it does not treat established severe hypertension.

Practical support can improve safety. A home blood pressure log should record the date, time, reading, symptoms and medication timing. Patients should bring the monitor to an appointment for comparison, keep an up-to-date medicine list and tell every clinician about pregnancy or breastfeeding. In remote areas, a local GP, Aboriginal Community Controlled Health Service, midwife and tertiary hospital may share responsibility for surveillance and escalation.

Actions that support safer care

• Check blood pressure using a validated monitor and the correct cuff size.
• Seek urgent assessment for readings of 160/110 mmHg or higher, especially if repeated.
• Report headache, visual symptoms, upper-abdominal pain, breathlessness or reduced fetal movement promptly.
• Review ACE inhibitors, ARBs and other regular medicines before conception or as soon as pregnancy is confirmed.
• Keep pathology, ultrasound and medication information available to every maternity-care provider.
• Arrange postpartum blood pressure review because complications can emerge after discharge.
• Ask about cardiovascular risk follow-up after a pregnancy affected by hypertension.

Reliable education helps families understand why treatment may change during pregnancy and after birth. The archived FAOPS 2020 congress site reflects the wider perinatal medicine community’s interest in research, neonatal care and collaborative clinical learning, subjects that remain relevant to Australian maternity services even when care is delivered locally.

A timely review with a GP, midwife or obstetric team can establish the diagnosis, select a pregnancy-compatible medicine and create a clear escalation plan. Keep the blood pressure record, medication list and recent test results together, and contact the maternity service promptly whenever readings rise or symptoms appear.